RAGE Modulator (University of Pittsburgh/University of Pittsburgh-Office of Technology Management)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRAGE Modulator (University of Pittsburgh/University of Pittsburgh-Office of Technology Management)
Drug Alias NameRAGE Modulator (University of Pittsburgh)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAdvanced glycosylation end product-specific receptor modulators
TargetsAdvanced glycosylation end product-specific receptor
Therapy Area/IndicationsFibrosisAsthmaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Pittsburgh
Active IndicationsN/A
Inactive IndicationsFibrosisAsthmaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A